28
Participants
Start Date
April 24, 2024
Primary Completion Date
December 22, 2024
Study Completion Date
January 7, 2025
Plixorafenib
Oral Tablet
Cobicistat
PPD - Austin Research Unit, Austin
Lead Sponsor
Fore Biotherapeutics
INDUSTRY